Researchers have employed immunohistochemistry to demonstrate that in cholangiocarcinoma tissue samples, both OGT and overall O‐GlcNAcylation levels exhibit significant elevation, while OGA levels are concurrently found to be reduced.272. This evidence concerns the gene OGA and cholangiocarcinoma.